FLGT

FLGT

USD

Fulgent Genetics Inc. Common Stock

$22.880-0.060 (-0.262%)

Prix en Temps Réel

Healthcare
Diagnostics & Research
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$22.940

Haut

$23.100

Bas

$22.631

Volume

0.01M

Fondamentaux de l'Entreprise

Capitalisation Boursière

700.3M

Industrie

Diagnostics & Research

Pays

United States

Statistiques de Trading

Volume Moyen

0.22M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $14.57Actuel $22.880Haut $24.64

Actualités Connexes

Analyst Upgrades

UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30

UBS analyst Lu Li upgrades Fulgent Genetics from Neutral to Buy and raises the price target from $20 to $30.

Voir plus
UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30
Analyst Upgrades

Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $21

Piper Sandler analyst David Westenberg maintains Fulgent Genetics with a Neutral and lowers the price target from $23 to $21.

Voir plus
Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $21
Earnings Call Transcripts

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Voir plus
Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript
BusinessWire

Fulgent Reports Second Quarter 2025 Financial Results

Core Revenue of $81.7 million grows 16% year-over-year Raising Full Year 2025 Core Revenue Guidance to $320 million GAAP gross profit of $34.4 million, or GAAP gross margin of 42.1%; Non-GAAP gross profit of

Voir plus
Fulgent Reports Second Quarter 2025 Financial Results

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.